Arkolith/Insider Trading/CRXT/Form 4

Hernandez Joseph

DirectorClarus Therapeutics Holdings, Inc. (CRXT) · full profile →Form 4 · filed Apr 27, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 25, 2022Other(J)65K—$01.2M
Apr 25, 2022Other(J)1.2M—$01.2M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 25, 2022Grant(A)3.4M$1.00$3.4M3.4M

Transaction Codes

J
Other acquisition / disposition
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-22-021910) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML